Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec 16;12(12):1419.
doi: 10.3390/vaccines12121419.

The Dynamics of Antibody Titres Against SARS-CoV-2 in Vaccinated Healthcare Workers: A Systemic Literature Review

Affiliations
Review

The Dynamics of Antibody Titres Against SARS-CoV-2 in Vaccinated Healthcare Workers: A Systemic Literature Review

Vilija Gurkšnienė et al. Vaccines (Basel). .

Abstract

Background and Objectives: Given that COVID-19 vaccination is a relatively recent development, particularly when compared to immunisation against other diseases, it is crucial to assess its efficacy in vaccinated populations. This literature review analysed studies that monitored antibody titres against SARS-CoV-2 in healthcare workers who received COVID-19 vaccines. Methods: Using the PICO (Population, Intervention, Comparators, Outcomes) model recommended in the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines we included 43 publications which analyse antibody dynamics following primary vaccination, the effects of booster doses, and the influence of factors such as COVID-19C infection, age, and sex on antibody kinetics. Results: All the studies demonstrated a strong immunogenic response to the vaccines. Re-gardless of the vaccine used, over 95% of the pre-vaccination seronegative population be-came seropositive in all studies. Depending on the sampling intervals provided by the re-searchers, antibody levels were quantitatively highest during the first three months after vaccination, but levels inevitably declined over time. The monthly decline in antibodies observed in all these studies highlighted the necessity for booster doses. Studies analysing the impact of revaccination on antibody dynamics have confirmed that revaccination is an effective tool to boost humoral immunity against SARS-CoV-2. An-tibodies appear to persist for a longer period of time after revaccination, although they are subject to similar factors influencing antibody dynamics, such as age, comorbidities, and exposure to COVID-19. In addition, heterogeneous revaccination strategies have been shown to be more effective than homogeneous revaccination. Conclusions: Our review demonstrated that antibody levels against SARS-CoV-2 inevitably decline after vaccination, leaving the question of ongoing booster strategies open. The studies reviewed provided evidence of the effectiveness of booster vaccination, despite differences in age, sex, and prior COVID-19 infection. This suggests that repeated vaccination remains a highly effective method for mitigating the continued threat posed by COVID-19.

Keywords: COVID-19; antibodies; healthcare workers; vaccination.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
The publication selection process.

Similar articles

References

    1. WHO Coronavirus (COVID-19) Dashboard Overview. [(accessed on 15 September 2024)]. Available online: https://data.who.int/dashboards/covid19/cases?n=c.
    1. CDC COVID-19 Response Team Characteristics of Health Care Personnel with COVID-19—United States, February 12–April 9, 2020. MMWR Morb. Mortal. Wkly. Rep. 2020;69:477–481. doi: 10.15585/mmwr.mm6915e6. - DOI - PMC - PubMed
    1. Chen D., Hu C., Su F., Song Q., Wang Z. Exposure to SARS-CoV-2 in a high transmission setting increases the risk of severe COVID-19 compared with exposure to a low transmission setting? J. Travel. Med. 2020;27:taaa094. doi: 10.1093/jtm/taaa094. - DOI - PMC - PubMed
    1. Abo-Leyah H., Gallant S., Cassidy D., Giam Y.H., Killick J., Marshall B., Hay G., Snowdon C., Hothersall E.J., Pembridge T., et al. The protective effect of SARS-CoV-2 antibodies in Scottish healthcare workers. ERJ Open Res. 2021;7:00080–2021. doi: 10.1183/23120541.00080-2021. - DOI - PMC - PubMed
    1. Sabetian G., Moghadami M., Hashemizadeh Fard Haghighi L., Shahriarirad R., Fallahi M.J., Asmarian N., Moeini Y.S. COVID-19 infection among healthcare workers: A cross-sectional study in southwest Iran. Virol. J. 2021;18:58. doi: 10.1186/s12985-021-01532-0. - DOI - PMC - PubMed

LinkOut - more resources